# US 2021/0330333 A1 · Occlusion Systems

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0330333 A1
- Document ID: US20210330333A1
- Status: Published application
- Kind: A1
- Application number: 17/242,740
- Filed: 2021-04-28
- Published: 2021-10-28
- Earliest claimed: 2020-04-28
- Assignees: Terumo Kabushiki Kaisha
- Applicants: Terumo Corporation
- Inventors: Brian Gray; Anup Dasnurkar; Maricela Walker; Michael Martel; Hiroki Kamiuchi
- Web page: https://patentgrep.com/patent/US20210330333A1

## CPC

- A61B 17/12136: {Balloons}
- A61B 17/00491: {Surgical glue applicators}
- A61B 17/12122: {within the heart (for closing a cardiac septal defect A61B17/0057)}
- A61B 2017/00632: {Occluding a cavity, i.e. closing a blind opening}
- A61B 2017/00893: {pharmaceutically effective}
- A61B 2017/00951: {adhesive}
- A61B 2017/12095: {Threaded connection}
- A61M 2025/1054: {having detachable or disposable balloons}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

An occlusion device with particular utility in occlusion of left atrial appendages is described. The occlusion device utilizes an inflatable balloon comprising a proximal portion to inflate with an inflation fluid delivered by an outer catheter body and conform to a shape of the left atrial appendage and a distal portion to fill with an adhesive delivered by an inner catheter body. The distal portion of the inflatable balloon sticks to the tissue wall of the left atrial appendage. The outer catheter body is configured to position the inner catheter body inside the outer catheter body.

## Claims

### Claim 1

An occlusion system for occluding a treatment site, comprising:
an outer catheter having an elongated body and at least one lumen extending therethrough; an inner catheter disposed radially within the outer catheter;
a balloon assembly releasably connected to a distal end of the outer catheter via a detachment mechanism; and,
an adhesive-absorbing membrane located at a distal end of the balloon assembly; the adhesive-absorbing membrane configured to absorb a predetermined volume of adhesive delivered through the inner catheter and to expose the adhesive along an outer surface of the adhesive membrane.

### Claim 2 (depends on 1)

The occlusion system of claim 1, wherein the adhesive-absorbing membrane is configured to absorb or contain about 0.1 to 1 ml of adhesive.

### Claim 3 (depends on 1)

The occlusion system of claim 1, wherein the adhesive-absorbing membrane has a thickness within an inclusive range of about 0.001 inch to about 0.003 inch.

### Claim 4 (depends on 1)

The occlusion system of claim 1, wherein the adhesive-absorbing membrane is composed of a 13 denier PET fiber woven to have about 120 courses per inch.

### Claim 5 (depends on 1)

The occlusion system of claim 1, wherein pores of the adhesive-absorbing membrane have sizes in a range of about 3 microns-10 microns.

### Claim 6 (depends on 1)

The occlusion system of claim 1, wherein the adhesive-absorbing membrane comprises a plurality of fibers forming a series of interlocking loops.

### Claim 7 (depends on 1)

The occlusion system of claim 1, wherein the balloon assembly is configured to limit external exposure of the adhesive to only the distal end of the balloon assembly.

### Claim 8 (depends on 1)

The occlusion system of claim 1, wherein the balloon assembly comprises a proximal portion configured to be inflated with inflation fluid, and a distal portion configured to accept adhesive.

### Claim 9 (depends on 8)

The occlusion system of claim 8, wherein the adhesive-absorbing membrane of the distal portion of the balloon assembly is attached over a depression at a distal end of the proximal portion of the balloon assembly.

### Claim 10 (depends on 8)

The occlusion system of claim 8, wherein the inner catheter extends into the distal portion of the balloon assembly.

### Claim 11 (depends on 10)

The occlusion system of claim 10, further comprising a valve assembly positioned within the balloon assembly so as to separate the proximal portion from the distal portion of the balloon assembly, the valve assembly comprising a first valve configured to seal around the outer catheter and a second valve configured to seal around the inner catheter.

### Claim 12 (depends on 11)

The occlusion system of claim 11, wherein the at least one lumen of the outer catheter comprises an inflation lumen sized and configured to allow passage of inflation fluid into the proximal portion of the balloon assembly while the inner catheter is positioned within the inflation lumen.

### Claim 13

An occlusion system for occluding a treatment site in a heart, comprising:
an outer catheter having an elongated body and an inflation lumen extending therethrough; and,
a balloon assembly releasably connected to a distal end of the outer catheter via a detachment mechanism; the balloon assembly comprising an inflatable proximal portion configured to receive inflation fluid and a distal portion configured to accept adhesive; the balloon assembly further comprising a first valve preventing release of the inflation fluid outside of the balloon assembly, and a second valve preventing release of the inflation fluid into the distal portion.

### Claim 14 (depends on 13)

The occlusion system of claim 13, wherein the first valve and the second valve are arranged in a linear passage.

### Claim 15 (depends on 14)

The occlusion system of claim 14, wherein the first valve is configured to engage the outer catheter and wherein the second valve is configured to engage an inner catheter positioned within the inflation lumen of the outer catheter.

### Claim 16 (depends on 15)

The occlusion system of claim 15, wherein the inner catheter configured to deliver adhesive to the distal portion and wherein the outer catheter is configured to deliver inflation fluid through the inflation lumen while the inner catheter is positioned within the inflation lumen.

### Claim 17 (depends on 13)

The occlusion system of claim 13, wherein the distal portion comprises an adhesive-absorbing membrane configured to absorb a predetermined volume of adhesive and expose the adhesive on an outer surface of the adhesive-absorbing membrane.

### Claim 18 (depends on 13)

The occlusion system of claim 13, wherein the adhesive-absorbing membrane is woven to have a thickness within an inclusive range of about 0.001 inch to about 0.003 inch and has a pore size within an inclusive range of about 3-10 microns.

### Claim 19

A method for occluding blood flow in a left atrial appendage in a heart of a patient, comprising:
advancing a balloon assembly into a left atrial appendage;
inflating a first portion of the balloon assembly via an inflation lumen from an outer catheter;
delivering adhesive to a second portion of the balloon assembly;
absorbing the adhesive with an adhesive-absorbing membrane connected to the second portion of the balloon assembly so that the adhesive is exposed on an outer surface of the adhesive-absorbing membrane; and,
detaching the outer catheter from the balloon assembly.

### Claim 20 (depends on 19)

The method of claim 19, further comprising preventing inflation fluid from the first portion of the balloon assembly into the second portion of the balloon assembly.
